Levisonics
Levisonics, Inc. is a medical device startup founded in 2016 through collaboration between researchers at Boston University and Tulane University. The company focuses on developing a novel platform for blood coagulation analysis and fluid rheological measurement using acoustic tweezing technology. Their mission is to revolutionize coagulation testing by providing safer, more convenient, and comprehensive point-of-care solutions that are portable, non-contact, and capable of delivering real-time actionable results. Levisonics aims to improve healthcare outcomes through innovative diagnostic tools that are suitable for use outside traditional hospital settings, including pediatric, anticoagulant therapy, and trauma management, as well as applications in industry such as quality control and biomedical research.
Industries
Nr. of Employees
small (1-50)
Levisonics
9059 Technology Ln, Fishers, IN 46038
Products
Portable non-contact single-drop coagulation analyzer (prototype)
A compact benchtop diagnostic platform that performs non-contact rheological and optical analysis of a single-drop blood sample to generate comprehensive coagulation profiles.
Portable non-contact single-drop coagulation analyzer (prototype)
A compact benchtop diagnostic platform that performs non-contact rheological and optical analysis of a single-drop blood sample to generate comprehensive coagulation profiles.
Services
Design and build of compact benchtop prototypes including PCB integration and hardware optimization for single-drop coagulation testing.
Collaborative testing and validation of device prototypes using whole blood and capillary samples with academic clinical partners.
Development of automated sample mixing, deployment, and containment mechanisms to enable repeatable single-drop assays suitable for point-of-care use.
Execution and management of government-funded projects (SBIR/STTR, DoD, NIH, NSF) to advance prototype development, regulatory planning, and commercialization strategy.
Design and build of compact benchtop prototypes including PCB integration and hardware optimization for single-drop coagulation testing.
Collaborative testing and validation of device prototypes using whole blood and capillary samples with academic clinical partners.
Development of automated sample mixing, deployment, and containment mechanisms to enable repeatable single-drop assays suitable for point-of-care use.
Execution and management of government-funded projects (SBIR/STTR, DoD, NIH, NSF) to advance prototype development, regulatory planning, and commercialization strategy.
Expertise Areas
- Blood coagulation analysis
- Point-of-care diagnostic device development
- Blood rheology and viscoelastic measurement
- Assay development for PT/aPTT, thrombin generation, and platelet function
Key Technologies
- Acoustic levitation / acoustic tweezing spectroscopy
- Viscoelastic (elastometric) measurement
- Photo-optical (turbidimetric) measurement
- Drop-of-sample rheometry
News & Updates
Levisonics received a $299,000 award from the NIH for a project to revolutionize coagulation monitoring in hemophilia patients using acoustic tweezing spectroscopy.
Support for blood coagulation analysis in pediatric patients.
A significant milestone for the company, focusing on point-of-care diagnosis and management of trauma patients.
Research shows a strong correlation between acoustic tweezing spectroscopy and standard lab coagulation tests PT and aPTT.
Recognition as a promising early-stage startup in Indiana, highlighting leadership and innovation.
Discussion on future developments and integration of coagulation management technology with IoT in healthcare.
Levisonics received a $299,000 award from the NIH for a project to revolutionize coagulation monitoring in hemophilia patients using acoustic tweezing spectroscopy.
Support for blood coagulation analysis in pediatric patients.
A significant milestone for the company, focusing on point-of-care diagnosis and management of trauma patients.
Research shows a strong correlation between acoustic tweezing spectroscopy and standard lab coagulation tests PT and aPTT.
Recognition as a promising early-stage startup in Indiana, highlighting leadership and innovation.
Discussion on future developments and integration of coagulation management technology with IoT in healthcare.